DK0421297T3 - Injicerbare præparater indeholdende cephalosporin som lægemiddel og anvendelse deraf - Google Patents

Injicerbare præparater indeholdende cephalosporin som lægemiddel og anvendelse deraf

Info

Publication number: DK0421297T3
Authority: DK; Denmark
Prior art keywords: cephalosporin; drug; salt; preparations containing; injectable preparations
Prior art date: 1989-09-30

Application number

DK90118682.5T

Other languages

English (en)

Inventor

Yasuo Ishibashi

Isamu Hasegawa

Masanori Kayano

Ryoichi Machida

Masahiro Kawahara

Sumio Watanabe

Original Assignee

Eisai Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-09-30

Filing date

1990-09-28

Publication date

1994-01-17

1990-09-28 Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd

1994-01-17 Application granted granted Critical

1994-01-17 Publication of DK0421297T3 publication Critical patent/DK0421297T3/da

Links

229930186147 Cephalosporin Natural products 0.000 title abstract 4
229940124587 cephalosporin Drugs 0.000 title abstract 4
150000001780 cephalosporins Chemical class 0.000 title abstract 4
238000002360 preparation method Methods 0.000 title abstract 4
239000003814 drug Substances 0.000 title abstract 3
229940079593 drug Drugs 0.000 title 1
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 6
150000003839 salts Chemical class 0.000 abstract 3
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
239000008101 lactose Substances 0.000 abstract 2
159000000000 sodium salts Chemical class 0.000 abstract 2
239000004475 Arginine Substances 0.000 abstract 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
239000011780 sodium chloride Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cephalosporin Compounds (AREA)
Medicinal Preparation (AREA)

DK90118682.5T 1989-09-30 1990-09-28 Injicerbare præparater indeholdende cephalosporin som lægemiddel og anvendelse deraf DK0421297T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP25378289		1989-09-30

Publications (1)

Publication Number	Publication Date
DK0421297T3 true DK0421297T3 (da)	1994-01-17

Family

ID=17256076

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK90118682.5T DK0421297T3 (da)	1989-09-30	1990-09-28	Injicerbare præparater indeholdende cephalosporin som lægemiddel og anvendelse deraf

Country Status (10)

Country	Link
US (1)	US5254545A (da)
EP (1)	EP0421297B1 (da)
JP (1)	JP3129428B2 (da)
KR (1)	KR950013760B1 (da)
CN (1)	CN1046632C (da)
AT (1)	ATE97810T1 (da)
CA (1)	CA2026516C (da)
DE (1)	DE69004921T2 (da)
DK (1)	DK0421297T3 (da)
ES (1)	ES2059947T3 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0840907A (ja)	1994-08-03	1996-02-13	Meiji Seika Kaisha Ltd	セファロスポリン注射剤
US5721229A (en) *	1995-12-26	1998-02-24	Veterinary Pharmacy Corporation	Soluble forms of cephalosporins and treatment of animals
UA80095C2 (en) *	2001-07-20	2007-08-27	Lilly Co Eli	2 methyl-thieno-benzodiazepine lyophilized formulation and method for the preparation thereof
EP1656930A1 (en) *	2004-11-10	2006-05-17	Basilea Pharmaceutica AG	Stabilized freeze-dried formulation for cephalosporin derivatives
AU2008302201A1 (en) *	2007-09-21	2009-03-26	Astrazeneca Ab	Soluble dosage forms containing cephem derivatives suitable for parenteral administration
CN103860484B (zh) *	2012-12-18	2016-08-24	四川科伦药业股份有限公司	注射用头孢妥仑钠冻干制剂及其制备方法
CN103860563B (zh) *	2012-12-18	2016-07-06	四川科伦药业股份有限公司	含头孢妥仑钠的药物组合物
WO2014158952A1 (en)	2013-03-13	2014-10-02	Theravance, Inc.	Hydrochloride salts of an antibiotic compound
KR102329764B1 (ko) *	2013-03-15	2021-11-23	머크 샤프 앤드 돔 코포레이션	세프톨로잔 항균성 조성물
US8906898B1 (en) *	2013-09-27	2014-12-09	Calixa Therapeutics, Inc.	Solid forms of ceftolozane
WO2016035846A1 (ja) *	2014-09-04	2016-03-10	塩野義製薬株式会社	カテコール基を有するセファロスポリン類を含有する製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2690009B2 (ja) *	1986-07-10	1997-12-10	エーザイ株式会社	セフアロスポリン注射剤
IL84128A (en) *	1986-10-13	1992-12-01	Eisai Co Ltd	3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
EP0612751A3 (en) *	1988-03-16	1994-09-21	Eisai Co Ltd	Compounds for the preparation of cephem derivatives.

1990
- 1990-09-28 DK DK90118682.5T patent/DK0421297T3/da active
- 1990-09-28 CA CA002026516A patent/CA2026516C/en not_active Expired - Fee Related
- 1990-09-28 US US07/589,922 patent/US5254545A/en not_active Expired - Fee Related
- 1990-09-28 JP JP02257401A patent/JP3129428B2/ja not_active Expired - Fee Related
- 1990-09-28 AT AT90118682T patent/ATE97810T1/de not_active IP Right Cessation
- 1990-09-28 DE DE90118682T patent/DE69004921T2/de not_active Expired - Fee Related
- 1990-09-28 ES ES90118682T patent/ES2059947T3/es not_active Expired - Lifetime
- 1990-09-28 EP EP90118682A patent/EP0421297B1/en not_active Expired - Lifetime
- 1990-09-29 CN CN90108130A patent/CN1046632C/zh not_active Expired - Fee Related
- 1990-09-29 KR KR1019900015756A patent/KR950013760B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69004921T2 (de)	1994-05-05
CN1050501A (zh)	1991-04-10
EP0421297A3 (en)	1991-06-12
US5254545A (en)	1993-10-19
JPH03173822A (ja)	1991-07-29
ATE97810T1 (de)	1993-12-15
EP0421297B1 (en)	1993-12-01
KR910005871A (ko)	1991-04-27
ES2059947T3 (es)	1994-11-16
KR950013760B1 (ko)	1995-11-15
EP0421297A2 (en)	1991-04-10
DE69004921D1 (de)	1994-01-13
JP3129428B2 (ja)	2001-01-29
CA2026516A1 (en)	1991-03-31
CN1046632C (zh)	1999-11-24
CA2026516C (en)	1998-02-17

Publication	Publication Date	Title
AU617918B2 (en)	1991-12-05	2-aminopyrimidinone derivatives
NO932745D0 (no)	1993-07-30	Triazolyltiometyltiocefalosporin-hydroklorid, dets krystalliske hydrat samt fremgangsmaate for fremstilling
BR9503536A (pt)	1996-06-04	Composto processo para sua preparação seu uso e composição farmacêutica
DE69004921D1 (de)	1994-01-13	Injizierbare Cephalosporinpräparate und ihre Anwendung.
AU3917189A (en)	1990-03-08	Antipsychotic 3-piperazinyl benzazole, benzisoxazole and benzisothiazole derivatives
HU900063D0 (en)	1990-03-28	Process for preparation of new 2-amino-pyrimidinone-derivatives
PH25532A (en)	1991-07-24	Novel n-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives, pharm,aceutical composition containing said compound, method of use thereof
FI893426A0 (fi)	1989-07-14	Analogiamenetelmä terapeuttisesti käyttökelpoisten BU-3608-johdannaisten ja niiden suolojen valmistamiseksi
ES2045067T3 (es)	1994-01-16	Procedimiento para preparar nuevos compuestos de tiazol.
CY1870A (en)	1996-04-05	Derivatives of penciclovir for the treatment of hepatitis-B infections
AU7506591A (en)	1991-10-24	A therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives
ES2004255A6 (es)	1988-12-16	Procedimiento de preparar compuestos del tipo de las piracinas y analogos.